Loading organizations...
§ Venture Capital · Delaware City, DE, USA
Medvance Incubator Partners operates as an early-stage venture fund, providing specialized financial and strategic support within the medical technology sector. The firm targets biotechnology, healthcare, and medical device innovators, functioning as an incubation partner. It supplies capital and resources to foster promising medical innovations from initial development.
Amr Salahieh, founder of Shifamed LLC, a prominent medical technology innovation hub, established the firm. Recognizing a critical financing gap for early-stage medical device companies, Salahieh and his team formed Medvance Incubator Partners. This fund arose from a partnership with Shifamed LLC and Delos Capital to deliver essential capital and guidance.
Medvance Incubator Partners serves entrepreneurs and companies developing novel medical devices and healthcare solutions. The firm aims to accelerate market entry for transformative medical technologies via tailored investment and strategic guidance. Its vision is to build a robust portfolio addressing significant unmet needs across global healthcare.
Medvance Incubator Partners has 3 tracked investments across 2 companies. The latest tracked deal is $10.0M Series C Extension in Atia Vision in December 2018.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Dec 10, 2018 | Atia Vision | $10.0M Series C Extension | The Capital Partnership | Cormorant Asset Management |
| May 1, 2015 | Atia Vision | $3.0M Series B | Medvance Incubator Partners | ARTIS Ventures |
| Jan 16, 2015 | Apama Medical | $11.0M Series B | Tara Butler | Incept, ONSET Ventures |